– Eir Partners Capital, LP is a private equity firm focused on health tech and tech-enabled services
– The firm announced the final close of Eir Partners III (Fund III)
– Fund III exceeded its original $800 million target and closed with $1 billion in commitments
– Eir emphasizes long-term alignment with limited partners through a substantial GP commitment, including in Fund III
Fund III was raised in just three months
– The investor base includes endowments, consultants, foundations, family offices, pension funds, and insurance companies
– The fund received continued support from long-time limited partners as well as new investors
– The rapid fundraising reflects Eir’s 10-year track record of disciplined healthcare investments
– Eir invests across payer, provider, employer, and pharma technology sectors
– Founder and CEO Brett S. Carlson highlighted the firm’s ability to execute deals across market cycles
– Eir focuses on building strategic platforms with differentiated healthcare technology products
– The firm has a proven track record of scaling mid-stage growth companies
– Institutional investors are attracted to Eir for exposure to next-generation category leaders and disruptors
– Since 2015, Eir has completed more than 50 transactions across 14 platform investments
– The firm’s deep network and long-standing relationships are expected to drive value in Fund III
– To date, Eir has raised $1.8 billion in total capital
Fund II closed at $496 million in 2024
Fund I closed at $255 million in 2021
– Lazard Frères & Co. LLC acted as exclusive placement advisor
– Cooley LLP served as legal counsel for the formation of Fund III
